Phase 2 Study of NGM282 in Patients With Primary Sclerosing Cholangitis



Status:Completed
Conditions:Gastrointestinal, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 75
Updated:7/20/2018
Start Date:March 2016
End Date:June 2017

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase 2, Randomized, Double Blind, Placebo Controlled, Parallel Group, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of NGM282 Administered for 12 Weeks in Patients With Primary Sclerosing Cholangitis

The purpose of this study is to determine the safety, tolerability, and activity of NGM282 in
patients with Primary Sclerosing Cholangitis.


Inclusion Criteria:

- Confirmed diagnosis of PSC

Exclusion Criteria:

- Clinically significant acute or chronic liver disease of an etiology other than PSC

- Secondary or IgG4 related sclerosing cholangitis
We found this trial at
25
sites
NGM Clinical Study Site 904
Charlottesville, Virginia
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
NGM Clinical Study Site 106
Aurora, Colorado
?
mi
from
Aurora, CO
Click here to add this to my saved trials
NGM Clinical Study Site 120
Cincinnati, Ohio
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
NGM Clinical Study Site 910
Dallas, Texas
?
mi
from
Dallas, TX
Click here to add this to my saved trials
NGM Clinical Study Site 101
Detroit, Michigan
?
mi
from
Detroit, MI
Click here to add this to my saved trials
NGM Clinical Study Site 903
Durham, North Carolina
?
mi
from
Durham, NC
Click here to add this to my saved trials
NGM Clinical Study Site 110
Gainesville, Florida
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
NGM Clinical Study Site 119
Houston, Texas
?
mi
from
Houston, TX
Click here to add this to my saved trials
NGM Clinical Study Site 109
Indianapolis, Indiana
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
NGM Clinical Study Site 102
Kansas City, Missouri
?
mi
from
Kansas City, MO
Click here to add this to my saved trials
NGM Clinical Study Site 124
Lakewood Ranch, Florida
?
mi
from
Lakewood Ranch, FL
Click here to add this to my saved trials
NGM Clinical Study Site 105
Miami, Florida
?
mi
from
Miami, FL
Click here to add this to my saved trials
NGM Clinical Study Site 114
Nashville, Tennessee
?
mi
from
Nashville, TN
Click here to add this to my saved trials
NGM Clinical Study Site 103
New York, New York
?
mi
from
New York, NY
Click here to add this to my saved trials
NGM Clinical Study Site 912
Newport News, Virginia
?
mi
from
Newport News, VA
Click here to add this to my saved trials
NGM Clinical Study Site 101
Norfolk, Virginia
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
NGM Clinical Study Site 301
Paris,
?
mi
from
Paris,
Click here to add this to my saved trials
NGM Clinical Study Site 911
Richmond, Virginia
?
mi
from
Richmond, VA
Click here to add this to my saved trials
NGM Clinical Study Site 118
Sacramento, California
?
mi
from
Sacramento, CA
Click here to add this to my saved trials
NGM Clinical Study Site 107
Saint Louis, Missouri
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
NGM Clinical Study Site 112
San Clemente, California
?
mi
from
San Clemente, CA
Click here to add this to my saved trials
NGM Clinical Study Site 127
San Francisco, California
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
NGM Clinical Study Site 908
Seattle, Washington
?
mi
from
Seattle, WA
Click here to add this to my saved trials
NGM Clinical Study Site 125
Southlake, Texas
?
mi
from
Southlake, TX
Click here to add this to my saved trials
NGM Clinical Study Site 115
Washington, District of Columbia
?
mi
from
Washington,
Click here to add this to my saved trials